The Role of Autologous Micrografts Injection from Scalp Tissue in the Treatment of COVID-19 Associated Telogen Effluvium: Clinical and Trichoscopic Evaluation

April 2022 in “ Dermatologic Therapy ”

Soha Abdalla Hawwam, Mayada Ismail, Esraa E El-Hawary

autologous micrografts scalp tissue Telogen Effluvium COVID-19 hair density hair thickness human follicle stem cells HFSCs TE

TLDR Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

The study conducted from June 2020 to June 2021 involved 20 female patients aged 30-45 years who had increased hair loss after COVID-19 infection. The research aimed to evaluate the effectiveness of autologous micrografts injection from the scalp tissue in treating Telogen Effluvium (TE) caused by COVID-19. The results showed significant improvement in hair density and thickness after 6 months of treatment, with mean hair density increasing from 184.1 ± 40.9 to 192.9 ± 39.6, and mean hair thickness improving from 0.06 ± 0.01 to 0.08 ± 0.01. No side effects or pain were reported during the procedures. The study concluded that human follicle stem cells (HFSCs) micrograft could be a safe and effective treatment for TE, recommending further long-term studies to evaluate the prognosis of TE associated with COVID-19 infection.

View this study on onlinelibrary.wiley.com →

Discuss this study in the Community →

Research cited in this study

12 / 12 results

The Role of Autologous Micrografts Injection from Scalp Tissue in the Treatment of COVID-19 Associated Telogen Effluvium: Clinical and Trichoscopic Evaluation

research The Role of Autologous Micrografts Injection from Scalp Tissue in the Treatment of COVID-19 Associated Telogen Effluvium: Clinical and Trichoscopic Evaluation

4 citations, April 2022 in “Dermatologic Therapy”

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

research Short-Term Efficacy of Autologous Cellular Micrografts in Male and Female Androgenetic Alopecia: A Retrospective Cohort Study

3 citations, November 2021 in “Clinical, Cosmetic and Investigational Dermatology”

Autologous cellular micrografts improve hair density and thickness in the short term for androgenetic alopecia.

research Telogen Effluvium Associated with COVID-19 Infection

44 citations, January 2021 in “Dermatologic Therapy”

COVID-19 may cause hair loss due to infection stress or treatments.

research Telogen Effluvium: A Sequela of COVID-19

58 citations, November 2020 in “International Journal of Dermatology”

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

research A Review of the Dermatological Manifestations of Coronavirus Disease 2019 (COVID-19)

26 citations, August 2020 in “Dermatology Research and Practice”

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

research Telogen Effluvium: A Review of the Literature

40 citations, May 2020 in “Cureus”

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

research Management of Telogen Effluvium During the COVID-19 Emergency: Psychological Implications

31 citations, May 2020 in “Dermatologic Therapy”

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

research Autologous Micrografts from Scalp Tissue: Trichoscopic and Long-Term Clinical Evaluation in Male and Female Androgenetic Alopecia

41 citations, January 2020 in “BioMed Research International”

Micrografts improve hair density and thickness without side effects.

Advances in Regenerative Stem Cell Therapy in Androgenic Alopecia and Hair Loss: Wnt Pathway, Growth Factor, and Mesenchymal Stem Cell Signaling Impact Analysis on Cell Growth and Hair Follicle Development

research Advances in Regenerative Stem Cell Therapy in Androgenic Alopecia and Hair Loss: Wnt Pathway, Growth Factor, and Mesenchymal Stem Cell Signaling Impact Analysis on Cell Growth and Hair Follicle Development

136 citations, May 2019 in “Cells”

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

Platelet-Rich Plasma and Micrografts Enriched with Autologous Human Follicle Mesenchymal Stem Cells Improve Hair Regrowth in Androgenetic Alopecia: Biomolecular Pathway Analysis and Clinical Evaluation

research Platelet-Rich Plasma and Micrografts Enriched with Autologous Human Follicle Mesenchymal Stem Cells Improve Hair Regrowth in Androgenetic Alopecia: Biomolecular Pathway Analysis and Clinical Evaluation

69 citations, April 2019 in “Biomedicines”

PRP and HF-MSCs treatment improves hair growth, thickness, and density in androgenetic alopecia.

research Therapeutic Potential of Stem Cells in Follicle Regeneration

45 citations, August 2018 in “Stem Cells International”

Stem cells, especially from fat tissue and Wharton's jelly, can potentially regenerate hair follicles and treat hair loss, but more research is needed to perfect the treatment.

Stem Cells from Human Hair Follicles: First Mechanical Isolation for Immediate Autologous Clinical Use in Androgenetic Alopecia and Hair Loss

research Stem Cells from Human Hair Follicles: First Mechanical Isolation for Immediate Autologous Clinical Use in Androgenetic Alopecia and Hair Loss

86 citations, June 2017 in “Stem cell investigation”

Stem cells from hair follicles can safely treat hair loss.

Related Research

7 / 7 results

research Sensitive Scalp: An Epidemiologic Study in Patients with Hair Loss

1 citations, January 2022 in “Dermatology Reports”

Many people with hair loss, especially those with telogen effluvium and alopecia areata, often have a sensitive scalp.

research Autologous Whole Fat Injection Stimulates Hair Growth in Resistant Androgenetic Alopecia: Report of Nine Cases

3 citations, December 2020 in “Journal of Cosmetic Dermatology”

Fat injections can help regrow hair in stubborn hair loss cases.

research A Clinico-Epidemiological Study of Scalp Hair Loss in Children (0–18 Years) in Kota Region, South-East Rajasthan

6 citations, January 2019 in “Indian Journal of Dermatology”

About 12% of children in Kota, Rajasthan, experience hair loss, mainly due to fungal infections, with early treatment advised to prevent worsening.

research Psoriatic Alopecia in a Patient with Systemic Lupus Erythematosus

3 citations, March 2017 in “Case Reports in Dermatology”

A woman with lupus improved significantly from scalp hair loss after treatment, highlighting the need to identify psoriatic alopecia in lupus patients to avoid permanent hair loss.

research Hair Loss in Children: Common and Uncommon Causes; Clinical and Epidemiological Study in Jordan

30 citations, January 2013 in “International Journal of Trichology”

The most common causes of hair loss in Jordanian children are fungal infections, autoimmune hair loss, and hair shedding after fever, with zinc deficiency also being a notable cause.

research Ambiguous Alopecia in a 36-Year-Old Woman

October 2012

The woman has unexplained hair loss and it's unclear what her condition is or how to treat it.

research Alopecia Areata: Clinical Presentation, Diagnosis, and Unusual Cases

109 citations, May 2011 in “Dermatologic Therapy”

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.